USA: Researchers have found in a new study that treatment with abrocitinib enabled more patients with atopic dermatitis to ...

Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life. Casey Butrus, PharmD: Dr Cameron, what’s the typical onset of action when you’re looking at a ...

Steve Feldman, MD, PhD, of Wake Forest University School of Medicine, discusses various effective treatments for alleviating itch in patients with atopic dermatitis (AD), including dupilumab and Janus ...

- VTAMA® (tapinarof) cream, 1% demonstrated early, significant, and meaningful achievement of both no-to-minimal itch (mean weekly PP-NRS≤1) and sleep improvement in ADORING 1 and ADORING 2. - 31.4% ...

Long-term clinical data reveal that continuous systemic biologic therapy provides durable skin clearance and itch relief for ...

Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and irritated, and the itching can be so severe that it interferes with sleep and ...

How do dermatologists diagnose atopic dermatitis? To diagnose atopic dermatitis, also called eczema, a board-certified dermatologist carefully examines your (or your child's) skin and asks questions. ...

Atopic dermatitis (AD) is mainly characterized by cycles of skin rashes, intense itching, dryness, and skin sensitivity. But this chronic and relapsing condition can come with hidden challenges as ...

Shared pathogenesis between atopic dermatitis, vitiligo, and alopecia areata supports a unified approach that targets these common mechanisms, promising better treatment options for these ...

Please provide your email address to receive an email when new articles are posted on . Roflumilast cream 0.15% showed rapid itch reduction within 24 hours of first application. More than 40% of ...

Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to ...

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has accepted the submission of the extension of the ...